<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Ind Microbiol Biotechnol</journal-id><journal-id journal-id-type="iso-abbrev">J Ind Microbiol Biotechnol</journal-id><journal-id journal-id-type="publisher-id">jimb</journal-id><journal-title-group><journal-title>Journal of Industrial Microbiology &#x00026; Biotechnology</journal-title></journal-title-group><issn pub-type="ppub">1367-5435</issn><issn pub-type="epub">1476-5535</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">9113183</article-id><article-id pub-id-type="pmid">33928358</article-id><article-id pub-id-type="doi">10.1093/jimb/kuab001</article-id><article-id pub-id-type="publisher-id">kuab001</article-id><article-categories><subj-group subj-group-type="heading"><subject>Natural Products</subject><subj-group subj-group-type="category-toc-heading"><subject>Mini-Review</subject></subj-group></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/SCI01150</subject><subject>AcademicSubjects/SCI00540</subject></subj-group></article-categories><title-group><article-title>Biosynthesis of sulfonamide and sulfamate antibiotics in actinomycete</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Awakawa</surname><given-names>Takayoshi</given-names></name><!--awakawa@mol.f.u-tokyo.ac.jp--><aff><institution>Graduate School of Pharmaceutical Sciences, The University of Tokyo</institution>, Bunkyo-ku, Tokyo 113-0033, <country country="JP">Japan</country></aff><aff><institution>Collaborative Research Institute for Innovative Microbiology, The University of Tokyo</institution>, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-8657, <country country="JP">Japan</country></aff><xref rid="cor1" ref-type="corresp"/><xref rid="afn1" ref-type="author-notes"/></contrib><contrib contrib-type="author"><name><surname>Barra</surname><given-names>Lena</given-names></name><aff><institution>Graduate School of Pharmaceutical Sciences, The University of Tokyo</institution>, Bunkyo-ku, Tokyo 113-0033, <country country="JP">Japan</country></aff><xref rid="afn1" ref-type="author-notes"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3640-888X</contrib-id><name><surname>Abe</surname><given-names>Ikuro</given-names></name><!--abei@mol.f.u-tokyo.ac.jp--><aff><institution>Graduate School of Pharmaceutical Sciences, The University of Tokyo</institution>, Bunkyo-ku, Tokyo 113-0033, <country country="JP">Japan</country></aff><aff><institution>Collaborative Research Institute for Innovative Microbiology, The University of Tokyo</institution>, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-8657, <country country="JP">Japan</country></aff><xref rid="cor2" ref-type="corresp"/></contrib></contrib-group><author-notes><corresp id="cor1">Correspondence should be addressed to: Takayoshi Awakawa at <email>awakawa@mol.f.u-tokyo.ac.jp</email></corresp><corresp id="cor2">Correspondence should be addressed to: Lena Barra at <email>abei@mol.f.u-tokyo.ac.jp</email></corresp><fn id="afn1"><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="collection"><month>4</month><year>2021</year></pub-date><pub-date pub-type="epub" iso-8601-date="2021-01-29"><day>29</day><month>1</month><year>2021</year></pub-date><pub-date pub-type="pmc-release"><day>29</day><month>1</month><year>2021</year></pub-date><volume>48</volume><issue>3-4</issue><elocation-id>kuab001</elocation-id><history><date date-type="accepted"><day>21</day><month>11</month><year>2020</year></date><date date-type="received"><day>28</day><month>9</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2021. Published by Oxford University Press on behalf of Society of Industrial Microbiology and Biotechnology.</copyright-statement><copyright-year>2021</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="kuab001.pdf"/><abstract><title>Abstract</title><p>Sulfonamides and sulfamates are a group of organosulfur compounds that contain the signature sulfamoyl structural motif. These compounds were initially only known as synthetic antibacterial drugs but were later also discovered as natural products. Eight highly potent examples have been isolated from actinomycetes to date, illustrating the large biosynthetic repertoire of this bacterial genus. For the biosynthesis of these compounds, several distinct and unique biosynthetic machineries have been discovered, capable to generate the unique S&#x02013;N bond. For the creation of novel, second generation natural products by biosynthetic engineering efforts, a detailed understanding of the underlying enzyme machinery toward potent structural motifs is crucial. In this review, we aim to summarize the current state of knowledge on sulfonamide and sulfamate biosynthesis. A detailed discussion for the secondary sulfamate ascamycin, the tertiary sulfonamide sulfadixiamycin A, and the secondary sulfonamide SB-203208 is provided and their bioactivities and mode of actions are discussed.</p></abstract><kwd-group kwd-group-type="keywords"><kwd>Sulfonamide</kwd><kwd>Sulfamates</kwd><kwd>Actinomycete</kwd><kwd>Bioactivity</kwd><kwd>Biosynthesis</kwd></kwd-group><funding-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Ministry of Education, Culture, Sports, Science and Technology</institution><institution-id institution-id-type="DOI">10.13039/501100001700</institution-id></institution-wrap>
</funding-source></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>JSPS</institution><institution-id institution-id-type="DOI">10.13039/501100001691</institution-id></institution-wrap>
</funding-source><award-id>JP16H06443</award-id><award-id>JP17H04763</award-id><award-id>JP19H04641</award-id><award-id>JP20H00490</award-id><award-id>JP20KK0173</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Japan Science and Technology Agency</institution><institution-id institution-id-type="DOI">10.13039/501100002241</institution-id></institution-wrap>
</funding-source></award-group><award-group award-type="grant"><award-id>JPMJSC1701</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Mochida Memorial Foundation for Medical and Pharmaceutical Research</institution><institution-id institution-id-type="DOI">10.13039/501100005865</institution-id></institution-wrap>
</funding-source></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Deutsche Forschungsgemeinschaft</institution><institution-id institution-id-type="DOI">10.13039/501100001659</institution-id></institution-wrap>
</funding-source><award-id>BA 6870/1-1</award-id></award-group></funding-group><counts><page-count count="8"/></counts></article-meta></front><body><sec sec-type="intro" id="sec1"><title>Introduction</title><p>Organosulfur compounds exhibit unique chemical properties due to the features of the inherent sulfur heteroatom and the arising reactivity. Sulfur is a third-period element and occupies the 3s, 3p, and sometimes 3d orbitals that are significantly larger than the second period elements orbitals (2s, 2p) such as oxygen or nitrogen. Additionally, sulfur is much less electronegative and organosulfur compounds with oxidation state +II, +IV, and +VI and coordination numbers from 0 to 7 are known (Block, <xref rid="bib6" ref-type="bibr">1978</xref>). Sulfonamides and sulfamates are organosulfur compounds that carry a sulfamoyl group represented by a tetrahedral sulfur atom connected to two oxygen, and one amine functionality (R<sup>1</sup>SO<sub>2</sub>NR<sup>2</sup><sub>2</sub>, R<sup>1</sup> = alkyl, aryl, R<sup>2</sup> = alkyl, aryl, or H). Whereas the sulfur atom is linked to an alkyl residue via a S&#x02013;C bond for sulfonamides, sulfamates exhibit an S&#x02013;O bond connecting the sulfamoyl group to an alkoxy residue. Sulfonamides are the amido analogs of sulfonic acids and the sulfur atom exhibits a +IV oxidation state. Sulfamates, on the other hand, can be regarded as the alkyl esters of sulfamic acid and are therefore the amido analogs of alkyl sulfates, exhibiting a sulfur atom in oxidation state +VI (Fig.&#x000a0;<xref rid="fig1" ref-type="fig">1</xref>).</p><fig position="float" id="fig1"><label>Fig. 1.</label><caption><p>Structural relationships of sulfonamides and sulfamates.</p></caption><graphic xlink:href="kuab001fig1" position="float"/></fig><p>Sulfonamides and sulfamates constitute a diverse family of highly pharmacologically active compounds and many clinically used drugs contain the signature sulfamoyl structural motif. Sulfonamides are widely known as synthetic &#x0201c;sulfa drugs&#x0201d;, and were the first chemotherapeutically used antibacterial compounds, represented by the most famous drug Prontosil (Brooks, <xref rid="bib7" ref-type="bibr">1989</xref>). Prontosil structurally resembles <italic toggle="yes">p</italic>-aminobenzoic acid, the native substrate of the dihydropteroate synthase, a key enzyme in bacterial folate biosynthesis (Ferone, <xref rid="bib12" ref-type="bibr">1977</xref>). A plethora of synthetic sulfamoyl containing compounds have been synthesized and drugs functioning as diuretics, uricosurics, hypoglycemic treatments, or antimicrobial have been developed (Brooks, <xref rid="bib7" ref-type="bibr">1989</xref>). While sulfonamides and sulfamates are mainly known as synthetic compounds, intriguingly, several examples were also discovered from natural sources (Petkowski et&#x000a0;al., <xref rid="bib29" ref-type="bibr">2018</xref>). The majority of these secondary metabolites are produced by actinomycetes, and primary sulfamates such as nucleocidin and dealanylascamycin (AT265), the primary sulfonamide altemicidin, the secondary sulfamates, ascamycin and sulphostin, the secondary sulfonamides SB-203207 and SB-203208, and the tertiary sulfonamide sulfadixiamycin A have been isolated (Fig.&#x000a0;<xref rid="fig2" ref-type="fig">2</xref>). Since the revolution of natural product sciences, caused by the development of genome and transcriptome sequencing technologies, the investigation and discovery of the genetic and biochemical basis of natural products biosynthesis opened the door for the development of novel drugs and drug leads by biosynthetic engineering. Given the pharmaceutical importance of sulfamoyl containing compounds such as sulfonamides and sulfamates, we here aim to summarize the current state of knowledge on sulfonamide and sulfamate biosynthesis in actinomycete. As the main topic of this review is the biosynthetic reaction for S&#x02013;N bond formation, see Waldman et&#x000a0;al. (<xref rid="bib36" ref-type="bibr">2017</xref>) for the overview of heteroatom&#x02013;heteroatom bond forming reaction in nature.</p><fig position="float" id="fig2"><label>Fig. 2.</label><caption><p>The structures of sulfamate and sulfonamide compounds from actinomycete.</p></caption><graphic xlink:href="kuab001fig2" position="float"/></fig></sec><sec id="sec2"><title>Biosynthesis of Sulfamate Compounds</title><p>Dealanylascamycin, ascamycin, and nucleocidin are rare 5&#x02032;-<italic toggle="yes">O</italic>-sulfamate nucleoside antibiotics isolated from <italic toggle="yes">Streptomyces</italic> sp. JCM9888 (Isono et&#x000a0;al., <xref rid="bib18" ref-type="bibr">1984</xref>; Morton et&#x000a0;al., <xref rid="bib23" ref-type="bibr">1969</xref>; Takahashi &#x00026; Beppu, <xref rid="bib34" ref-type="bibr">1982</xref>) (Fig.&#x000a0;<xref rid="fig3" ref-type="fig">3</xref>). Whereas dealanylascamycin and nucleocidin possess a primary sulfamate moiety, ascamycin carries an additional <italic toggle="yes">N</italic>-<sc>l</sc>-alanyl residue and can therefore be described as a secondary sulfamate. Notably, ascamycin and dealanylascamycin exhibit differing antimicrobial activities. Ascamycin possesses limited antibiotic properties and is active toward only a few bacterial species like <italic toggle="yes">Xanthomonas</italic>. Dealanylascamycin, on the other hand, exhibits a broader antibacterial spectrum against both gram-positive and gram-negative bacteria. Additionally, dealanylascamycin was found to have anti-trypanosomal and -amoebae activities. The detailed investigation of their mode of action showed that both compounds dealanylascamycin and ascamycin are able to inhibit protein synthesis by using a cell-free protein translation assay system (Osada &#x00026; Isono, <xref rid="bib27" ref-type="bibr">1985</xref>). The other study revealed that ascamycin is converted to dealanylascamycin by a hydrolyzing aminopeptidase in <italic toggle="yes">Xanthomonas campestris</italic> pv<italic toggle="yes">. citri</italic> (Osada &#x00026; Isono, <xref rid="bib28" ref-type="bibr">1986</xref>), and the authors proposed that the differing antimicrobial properties arise from differences in the ability to penetrate the cell membrane of target organisms, as only dealanylascamysin can be transferred into the cell. However, the target of dealanylascamycin in protein synthesis has not been identified.</p><fig position="float" id="fig3"><label>Fig. 3.</label><caption><p>The proposed ascamycin biosynthesis. (a) The organization of <italic toggle="yes">acm</italic> cluster. (b) The biosynthesis of ascamycin from adenosine. (c) The biosynthesis of PAPS from ATP.</p></caption><graphic xlink:href="kuab001fig3" position="float"/></fig><fig position="float" id="fig4"><label>Fig. 4.</label><caption><p>The biosynthesis of sulfadixiamycin A. (a) The organization of <italic toggle="yes">xia</italic> gene cluster. (b) <italic toggle="yes">N</italic>-hydroxylation-triggered dimerization of xiamycin via SO<sub>2</sub> by the flavin-binding enzyme XiaH.</p></caption><graphic xlink:href="kuab001fig4" position="float"/></fig><p>The cosmid harboring the biosynthetic gene cluster (<italic toggle="yes">acm</italic> cluster, Fig.&#x000a0;<xref rid="fig3" ref-type="fig">3a</xref>) for ascamycin biosynthesis was searched by using <italic toggle="yes">acmG</italic> (sulfatase) as a query, and the gene cluster was confirmed by gene inactivation of <italic toggle="yes">acmG</italic> and <italic toggle="yes">acmK</italic> (sulfotransferase) (Zhao et&#x000a0;al., <xref rid="bib43" ref-type="bibr">2014</xref>). In initial studies, the research group analyzed the function of AcmE, predicted as an esterase with weak homology to the identified aminopeptidase which hydrolyzes ascamycin to produce dealanylascamycin in <italic toggle="yes">Xanthomonas citri</italic> (Osada &#x00026; Isono, <xref rid="bib27" ref-type="bibr">1985</xref>). The <italic toggle="yes">acmE</italic>-inactivated mutant no longer produced ascamycin, but dealanylascamycin, suggesting the function of AcmE in the amidation of dealanylascamycin with the <sc>l</sc>-alanyl moiety in the late stage of the biosynthetic pathway (Fig.&#x000a0;<xref rid="fig3" ref-type="fig">3b</xref>). The <sc>l</sc>-alanyl moiety was hypothesized to be derived from alanyl-tRNA, since <italic toggle="yes">acmE</italic> is flanked by two acyl-tRNA synthetase genes (<italic toggle="yes">acmD</italic> and <italic toggle="yes">F</italic>); however, no biochemical evidence has been reported. The source of the sulfamoyl group has been proposed to be derived from a sulfate group, followed by its conversion into a sulfamate functionality. The first step was suggested to be catalyzed by the 3&#x02032;-phosphoadenosine 5&#x02032;-phosphosulfate (PAPS)-dependent sulfotransferase AcmK. PAPS-dependent sulfotransferases are a large family of enzymes that transfer a sulfuryl group from the donor co-substrate PAPS to a nucleophilic acceptor molecule. This common strategy for sulfo-group transfer is shared in many biosynthetic pathways and sulfotransferases acting on steroids, bioamines, therapeutic drugs, glucosaminylglycans, as well as proteins are known (Negishi et&#x000a0;al., <xref rid="bib24" ref-type="bibr">2001</xref>).</p><p>In the ascamycin gene cluster, PAPS itself in thereby suggested to be generated by the ATP sulfurylase AcmW and the adenylylsulfate kinase AcmB from two molecules of ATP and sulfate (Fig.&#x000a0;<xref rid="fig3" ref-type="fig">3c</xref>) (Negishi et&#x000a0;al., <xref rid="bib24" ref-type="bibr">2001</xref>; Petkowski et&#x000a0;al., <xref rid="bib29" ref-type="bibr">2018</xref>). The proposed adenosine-5&#x02032;-sulfonate intermediate is then further converted to dechloro-dealanylascamycin. Based on gene annotation and bioinformatic predictions, the authors hypothesized that the amidinotransferase AcmN is responsible for the S&#x02013;N bond formation event to yield the primary sulfamate. However, the sulfamate formation is highly likely to involve at least a second enzyme to catalyze the necessary modification of the attached amidino group, considering the catalysis of amidinotransferase (Humm et&#x000a0;al., <xref rid="bib17" ref-type="bibr">1997</xref>). The following halogenation was suggested to be catalyzed by the flavin-dependent halogenases AcmX or Y. Apart from the initial report on the identification of the <italic toggle="yes">acm</italic>-gene cluster (Zhao et&#x000a0;al., <xref rid="bib43" ref-type="bibr">2014</xref>), no detailed biochemical investigation on the function of the involved enzymes has been reported.</p><p>Nucleocidin contains a rare fluorine atom at the C-4&#x02032; position in the nucleoside core of ascamycin (Feng et&#x000a0;al., <xref rid="bib11" ref-type="bibr">2019</xref>; Morton et&#x000a0;al., <xref rid="bib23" ref-type="bibr">1969</xref>). The target of nucleocidin is also the bacterial protein biosynthesis similarly to dealanylascamycin, and it was shown to inhibit the incorporation of aminoacyl-tRNA into the ribosome (Florini et&#x000a0;al., <xref rid="bib13" ref-type="bibr">1966</xref>). Interestingly, nucleocidin was produced in <italic toggle="yes">Streptomyces calvus</italic> ATCC13382, only when a rare codon, Leu-tRNA<sup>UUA</sup> (<italic toggle="yes">bldA</italic>) was supplied. Its gene cluster (<italic toggle="yes">nuc</italic> cluster) was identified through gene deletion (Zhu et&#x000a0;al., <xref rid="bib44" ref-type="bibr">2015</xref>). Apart from early feeding experiments that showed incorporation of labeled glycerol into position C-5&#x02032; of nucleocidin, (Feng et&#x000a0;al., <xref rid="bib10" ref-type="bibr">2017</xref>), there is little knowledge on its biosynthesis. Considering that NucN, an ORF that has 48.7% similarity to AcmN, is encoded in <italic toggle="yes">nuc</italic> cluster, nucleocidin likely shares the same S&#x02013;N bond-forming mechanism with ascamycin biosynthesis. Apart from the cryptic sulfamate installation, the introduction of fluorine and how the C&#x02013;F bond is formed also remains enigmatic. A known mechanism for fluoride incorporation into SAM by 5&#x02032;-fluoro-5&#x02032;-deoxyadenosine synthase flA from the actinomycete <italic toggle="yes">Streptomtyces cattleya</italic> (O'Hagan et&#x000a0;al., <xref rid="bib26" ref-type="bibr">2002</xref>) has been reported, but no <italic toggle="yes">flA</italic> homolog is encoded in the <italic toggle="yes">nuc</italic> cluster, suggesting a novel mechanism for C&#x02013;F bond formation in nucleocidin biosynthesis.</p><p>Another sulfamate compound, sulphostin was isolated from <italic toggle="yes">Streptomyces</italic> sp. MK251-43F3 by the Institute of Microbial Chemistry (Akiyama et&#x000a0;al., <xref rid="bib1" ref-type="bibr">2001</xref>). This compound exhibits strong inhibitory activity against dipeptidyl peptidase IV that is a cell-surface serine peptidase that cleaves a dipeptide from the N-terminus of target proteins (De Meester et&#x000a0;al., <xref rid="bib8" ref-type="bibr">1999</xref>). Because dipeptidyl peptidase IV controls the insulin release and modulation of thymocyte activity, sulphostin likely possesses therapeutic potential for type II diabetes and immune disorders. From its structure, the biosynthetic precursor can be expected to be <sc>l</sc>-ornithine, however nothing is known about the biosynthesis of sulphostin.</p></sec><sec id="sec3"><title>Biosynthesis of Sulfadixiamycin A</title><p>Xiamycins are rare indole alkaloids with anti-HIV activities that possess a unique cyclic sesquiterpenoid structure and were isolated from mangrove-derived <italic toggle="yes">Streptomyces</italic> sp. HKI0576 (Ding et&#x000a0;al., <xref rid="bib9" ref-type="bibr">2010</xref>) and <italic toggle="yes">Streptomyces pactum</italic> SCSIO 02999 (Zhang et&#x000a0;al., <xref rid="bib42" ref-type="bibr">2012</xref>). The two biosynthetic clusters for xiamycin were identified in these two strains by Hertweck's group (Xu et&#x000a0;al., <xref rid="bib38" ref-type="bibr">2012</xref>) and by Zhang's group (Li et&#x000a0;al., <xref rid="bib19" ref-type="bibr">2012</xref>), respectively (<italic toggle="yes">xia</italic> cluster, the same name for these two clusters) (Fig.&#x000a0;<xref rid="fig3" ref-type="fig">3a</xref>). Heterologous expression of the <italic toggle="yes">xia</italic> gene cluster in <italic toggle="yes">Streptomyces albus</italic> by Hertweck's group led to production of several minor products including xiamycin dimers, named dixamycins, connected via a N&#x02013;C or N&#x02013;N bond (Baunach et&#x000a0;al., <xref rid="bib3" ref-type="bibr">2013</xref>). The promising antibacterial activity of dixiamycin prompted the researchers to further investigate the minor constituents from a 50 L culture of the <italic toggle="yes">S. albus</italic> expression strain. Three novel xiamycin analogs, possessing a unique sulfonyl-linkage between N-1&#x02032; and C-6 were isolated and named sulfadixiamycin A&#x02013;C (Baunach et&#x000a0;al., <xref rid="bib4" ref-type="bibr">2015</xref>). These compounds exhibit potent antibacterial activity against <italic toggle="yes">Bacillus subtilis, Staphylococcus aureus</italic>, and MRSA. The biological target of the sulfadixiamycines is still unknown, but given the unique structural features of these compounds, a distinct mechanism to other sulfa drugs seems likely.</p><p>In order to identify the key biosynthetic enzyme responsible for the S&#x02013;N bond formation, the authors deleted several ORFs encoding oxygenases in the <italic toggle="yes">xia</italic> cluster and deletion of <italic toggle="yes">xiaH</italic> led to a completely abolished production of dixiamycins including sulfadixiamycin A&#x02013;C, while it still produced xiamycin. This data clearly indicated that XiaH is responsible for the dimerization of xiamycin. XiaH is a flavin-binding oxygenase and the authors proposed a radical-initiated reaction mechanism and involvement of sulfite-derived sulfur dioxide (Baunach et&#x000a0;al., <xref rid="bib4" ref-type="bibr">2015</xref>). Zhang's group characterized the direct product of XiaH (XiaK in their gene cluster) as <italic toggle="yes">N</italic>-hydroxyxiamycin, and it spontaneously turned to be <italic toggle="yes">N</italic>-hydroxy radical adduct, in the mechanistic study <italic toggle="yes">in vitro</italic> (Zhang et&#x000a0;al., <xref rid="bib41" ref-type="bibr">2017</xref>). Based on the results from these two experiments, the reaction mechanism for sulfadixiamycin A biosynthesis can be proposed as below.</p><p>In the initial step, XiaH catalyzes <italic toggle="yes">N</italic>-hydroxylation, and the resultant <italic toggle="yes">N</italic>-hydroxyxiamycin spontaneously generates a nitroxy radical (Fig. <xref rid="fig4" ref-type="fig">4</xref>). The nitroxy radical undergoes dimerization accompanied with deoxygenation to yield a nitrogen radical. The nitrogen radical reacts with sulfur dioxide and yields a sulfonyl radical that upon recombination with another xiamycin radical builds up the N&#x02013;S&#x02013;C bond characteristic for sulfadixiamycin A. This radical reaction is reminiscent of synthetic methods for the polymerization of styrene and sulfur dioxide (Barb, <xref rid="bib2" ref-type="bibr">1952</xref>; Matsuda et&#x000a0;al., <xref rid="bib21" ref-type="bibr">1972</xref>), and an intriguing method by Nature to increase the complexity of natural products. In sulfadixiamycin B and C, the sulfur is bound to C-6 or C-21 of the aromatic indole moiety via C&#x02013;S&#x02013;C bond, indicating different resonance stabilized radical intermediates.</p></sec><sec id="sec4"><title>Biosynthesis of Altemicidin, SB-203207, and SB-203208</title><p>In 1989, altemicidin was isolated from the marine actinomycete <italic toggle="yes">Streptomyces sioyaensis</italic> SA-1758 in the course of a screening program for novel acaricidal substances (Fig.&#x000a0;<xref rid="fig5" ref-type="fig">5a</xref>) (Takahashi et&#x000a0;al., <xref rid="bib33" ref-type="bibr">1989</xref>). Altemicidin exhibits antitumor activity, as well as antibacterial activity specific toward <italic toggle="yes">Xanthomonas</italic> species, similar to ascamycin. The structure of altemicidin was determined as (1<italic toggle="yes">R</italic>,2<italic toggle="yes">S</italic>,3a<italic toggle="yes">R</italic>,7a<italic toggle="yes">S</italic>)-4-carbamoyl-2-hydroxy-6-methyl-1-(sulfamoylacetamido)-2,3,3a,6,7,7a-hexahydro-6-azainden-1-carboxylic acid, by NMR and X-ray crystallographic analyses after derivatization with 9-hydroxyxanthene (Takahashi et&#x000a0;al., <xref rid="bib32" ref-type="bibr">1989</xref>). In 2000, the two related compounds SB-203207 and SB-203208 were isolated from the soil actinomycete <italic toggle="yes">Streptomyces</italic> sp. NCIMB 40513 during a metabolite screening for new inhibitors of isoleucyl-tRNA synthetase (Houge-Frydrych et&#x000a0;al., <xref rid="bib14" ref-type="bibr">2000</xref>; Stefanska et&#x000a0;al., <xref rid="bib30" ref-type="bibr">2000</xref>). SB-203207 was found to inhibit the isoleucyl-tRNA synthetases from <italic toggle="yes">Staphylococcus, Pseudomonas, Candida</italic>, and Rat liver at IC<sub>50</sub> &#x0003c; 2 nM, while showing only weak inhibition of the isoleucyl-tRNA synthetase from the producer strain (IC<sub>50</sub> = 401 nM). This data implies the existence of a self-resistance mechanism in the SB-203207 producer strain. The proteins responsible for self-resistance against antibiotics are usually efflux pumps, modification enzymes, and homologs of target proteins with specific mutations to inhibit binding of the produced antibiotic. In recent years, the self-resistance gene-guided search for biosynthetic gene clusters has been demonstrated as a powerful tool (Tang et&#x000a0;al., <xref rid="bib35" ref-type="bibr">2015</xref>; Yan et&#x000a0;al., <xref rid="bib40" ref-type="bibr">2018</xref>, <xref rid="bib39" ref-type="bibr">2020</xref>).</p><fig position="float" id="fig5"><label>Fig. 5.</label><caption><p>The biosynthesis of SB-203208. (a) The organization of <italic toggle="yes">sbz</italic> cluster. (b) The aminoacyl-transfer reactions to produce SB-203208. (c) The multistep oxygenation catalyzed by SbzM and SbzJ to produce 2-sulfamoylacetic acid from <sc>l</sc>-cysteine.</p></caption><graphic xlink:href="kuab001fig5" position="float"/></fig><p>The SB-203208 biosynthetic gene cluster (<italic toggle="yes">sbz</italic> cluster) that contained genes encoding a putative self-resistance-related isoleucyl-tRNA synthetase (<italic toggle="yes">sbzA</italic>), MppJ-like methyltransferase (Huang et&#x000a0;al., <xref rid="bib16" ref-type="bibr">2009</xref>) (<italic toggle="yes">sbzD</italic>), two sets of AMP-ligases (<italic toggle="yes">sbzBL</italic>), and two carrier proteins (<italic toggle="yes">sbzGK</italic>), was found in the genome sequence of <italic toggle="yes">Streptomyces</italic> sp. NCIMB40513 (Hu et&#x000a0;al., <xref rid="bib15" ref-type="bibr">2019</xref>). The heterologous expression of the <italic toggle="yes">sbz</italic> cluster in <italic toggle="yes">Streptomyces lividans</italic> yielded the target compounds altemicidin (10 mg/l), SB-203207 (1.1 mg/l), and SB-203208 (1.8 mg/l). The primary sulfonamide group in altemicidin was shown to be derived from <sc>l</sc>-cysteine by feeding experiments and the key biosynthetic enzymes were identified to be a cupin oxygenase family enzyme (SbzM) and an NAD<sup>+</sup>-dependent aldehyde dehydrogenase (SbzJ) by gene inactivation. <italic toggle="yes">In vitro</italic> assays with SbzM and <sc>l</sc>-cysteine revealed a highly unusual oxidative rearrangement toward 2-sulfamoylacetic aldehyde. To monitor the reaction, two different labeling agents for carboxyl and aldehyde groups were utilized, as well as direct <sup>13</sup>C-NMR analysis of the SbzM reaction employing (<sup>13</sup>C<sub>3</sub>, <sup>15</sup>N<sub>1</sub>)cysteine. In the subsequent reaction, SbzJ was shown to oxidize the resulting aldehyde to the corresponding 2-sulfamoylacetic acid (Fig.&#x000a0;<xref rid="fig5" ref-type="fig">5b</xref>). The 2-sulfamoylacetic acid moiety is incorporated into the side chain of altemicidin by the action of a Gcm5-related <italic toggle="yes">N</italic>-acetyltransferase-like enzyme (SbzI). The altemicidin biosynthetic pathway was the first example of a cupin oxygenase-type derived sulfonamide.</p><p>The known cupin-type enzyme cysteine dioxygenase also accepts <sc>l</sc>-cysteine, but produces <sc>l</sc>-cysteine sulfinic acid (Stipanuk et&#x000a0;al., <xref rid="bib31" ref-type="bibr">2011</xref>). Mechanistically, it is proposed that the superoxide anion attacks the cationic sulfur to form the thiadioxirane intermediate (reaction i), which rearranges to <sc>l</sc>-cysteine sulfinic acid (reaction ii) (Fig.&#x000a0;<xref rid="fig6" ref-type="fig">6a</xref>) (Li et&#x000a0;al., <xref rid="bib20" ref-type="bibr">2019</xref>). In contrast, the SbzM reaction was suggested to involve proton abstraction at the &#x003b2;-position of <sc>l</sc>-cysteine by the superoxide species to produce the intermediate with a C&#x02013;S double bond (reaction i) as reported in the peptidyl-cysteine decarboxylase EpiD (Fig.&#x000a0;<xref rid="fig6" ref-type="fig">6b</xref>) (Blaesse et&#x000a0;al., <xref rid="bib5" ref-type="bibr">2000</xref>). The electrons move from the sulfur to the oxygen atom to produce an instable sulfine intermediate (McCaw et&#x000a0;al., <xref rid="bib22" ref-type="bibr">2016</xref>) (reaction ii) that spontaneously rearranges to the more stable (<italic toggle="yes">Z</italic>)-2-aminovinyl sulfanolate concomitantly with decarboxylation (reaction iii) (Fig.&#x000a0;<xref rid="fig6" ref-type="fig">6b</xref>). To shed light on the mechanistic differences in catalysis of SbzM to the related cysteine dioxygenase, simulation studies with models built from X-ray crystallographic data, together with spectroscopic experiments are required.</p><fig position="float" id="fig6"><label>Fig. 6.</label><caption><p>The hypothetical reaction mechanism of cysteine dioxygenase and SbzM. (a) The reaction mechanism of cysteine dioxygenase to produce <sc>l</sc>-cysteine sulfinic acid. (b) The hypothetical reaction mechanism of SbzM to produce (<italic toggle="yes">Z</italic>)-2-aminovinyl sulfanolate.</p></caption><graphic xlink:href="kuab001fig6" position="float"/></fig><p>SbzM homologs with high similarity (49.5&#x02013;96.5% similarity) are distributed among actinomycetes such as <italic toggle="yes">Streptomyces, Micromonospora, Amycolatopsis, Saccharopolyspora, Actinomadura, Actinokineospora, Actinocorallia, Microbiospora</italic>, and <italic toggle="yes">Pseudonocardia</italic> (Fig.&#x000a0;<xref rid="fig7" ref-type="fig">7</xref>). Some of these homologs are distributed in <italic toggle="yes">sbz</italic>-like cluster (Fig.&#x000a0;<xref rid="fig7" ref-type="fig">7A</xref>). More interestingly, the other homologs are clustered with genes encoding polyketide synthase (PKS) and AMP-ligase possibly to load a substrate for PKS (Fig.&#x000a0;<xref rid="fig7" ref-type="fig">7B</xref>), non-ribosomal peptide synthetase (NRPS) genes (Fig.&#x000a0;<xref rid="fig7" ref-type="fig">7C</xref>), and ATP-grasp enzymes that form amide bond (Fig.&#x000a0;<xref rid="fig7" ref-type="fig">7D</xref>) (Ogasawara &#x00026; Dairi, <xref rid="bib25" ref-type="bibr">2017</xref>; Walsh &#x00026; Tang, <xref rid="bib37" ref-type="bibr">2017</xref>). So far, there is no knowledge about natural products derived from these clusters, making them promising targets for the discovery of novel sulfonamide-containing secondary metabolites.</p><fig position="float" id="fig7"><label>Fig. 7.</label><caption><p>The phylogenetic tree analysis of SbzM homologs. Each biosynthetic gene is clustered with genes encoding SB-203208-type biosynthetic enzymes (A), PKS &#x00026; AMP ligase (B), NRPS (C), and ATP-grasp enzyme (D).</p></caption><graphic xlink:href="kuab001fig7" position="float"/></fig></sec><sec sec-type="conclusions" id="sec5"><title>Conclusion</title><p>In this review, we summarized the knowledge on the biosynthesis of antibiotic sulfamate and sulfonamide natural products from actinomycetes. Although there are still several questions unanswered, our current understanding reveals the occurrence of distinct chemical strategies for S&#x02013;N bond formation in known pathways. The sulfamate formation in ascamycin biosynthesis is proposed to be based on initial sulfate activation by anhydride formation (PAPS) and transfer of the sulfuryl group to the acceptor molecule by a sulfotransferase, followed by S&#x02013;N bond formation by an unknown mechanism. The sulfonamide formation in xiamycin biosynthesis on the other hand is based on oxidation-induced radical formation by a flavin-dependent enzyme and the use of SO<sub>2</sub> from the bacterial sulfur metabolism. The sulfonamide assembly in altemicidin, SB-203208, and SB-203207 biosynthesis utilizes cysteine and tailoring by a cupin-type oxygenase catalyzing an intriguing multistep reaction that involves oxidative decarboxylation, intramolecular nucleophilic substitution, and imine hydrolysis. The variety of these reactions are impressive examples for the versatile chemistries that have evolved in biosynthetic pathways toward highly potent secondary metabolites in actinomycetes. The strong and distinct bioactivities of the sulfamate and sulfonamide compounds make them privileged structures from Nature and novel strategies to diversify the family of these compounds is highly desirable. A detailed understanding of the underlying biosynthetic machineries will open the door to exploit them for the development of novel drugs or drug leads, biotechnological production of target compounds, or the development of new biocatalysts by protein engineering efforts.</p></sec></body><back><ack id="ack1"><title>Acknowledgments</title><p>The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.</p></ack><sec id="sec6"><title>Funding</title><p>This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (JSPS KAKENHI grant numbers JP16H06443, JP17H04763, JP19H04641, JP20H00490, and JP20KK0173), Japan Science and Technology Agency (JST SICORP grant number JPMJSC1701), Mochida Memorial Foundation for Medical and Pharmaceutical Research, and Takeda Science Foundation. We also thank the Deutsche Forschungsgemeinschaft (DFG BA 6870/1-1) for a postdoctoral research fellowship to L.B.</p></sec><sec id="sec7"><title>Conflict of Interest</title><p>The authors declare no conflict of interest.</p></sec><ref-list id="ref1"><title>References</title><ref id="bib1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Akiyama</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Abe</surname>
<given-names>M.</given-names></string-name>, <string-name><surname>Harada</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Kojima</surname>
<given-names>F.</given-names></string-name>, <string-name><surname>Sawa</surname>
<given-names>R.</given-names></string-name>, <string-name><surname>Takahashi</surname>
<given-names>Y.</given-names></string-name>, <string-name><surname>Naganawa</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Homma</surname>
<given-names>Y.</given-names></string-name>, <string-name><surname>Hamada</surname>
<given-names>M.</given-names></string-name>, <string-name><surname>Yamaguchi</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Aoyagi</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Muraoka</surname>
<given-names>Y.</given-names></string-name>, <string-name><surname>Takeuchi</surname>
<given-names>T.</given-names></string-name></person-group> (<year>2001</year>). <article-title>Sulphostin, a potent inhibitor for dipeptidyl peptidase IV from <italic toggle="yes">Streptomyces</italic> sp. MK251-43F3</article-title>. <source>Journal of Antibiotics</source>, <volume>54</volume>, <fpage>744</fpage>&#x02013;<lpage>746</lpage>. <pub-id pub-id-type="pmid">11714231</pub-id></mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barb</surname>
<given-names>W. G.</given-names></string-name></person-group> (<year>1952</year>). <article-title>The copolymerization of styrene and sulphur dioxide&#x02014;I. Properties and composition of the copolymer, and evidence for the existence of a styrene/sulphur dioxide complex</article-title>. <source>Proceedings of Royal Society of London Series A</source>, <volume>212</volume>, <fpage>66</fpage>&#x02013;<lpage>80</lpage>. </mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Baunach</surname>
<given-names>M.</given-names></string-name>, <string-name><surname>Ding</surname>
<given-names>L.</given-names></string-name>, <string-name><surname>Bruhn</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Bringmann</surname>
<given-names>G.</given-names></string-name>, <string-name><surname>Hertweck</surname>
<given-names>C.</given-names></string-name></person-group> (<year>2013</year>). <article-title>Regiodivergent N&#x02013;C and N&#x02013;N aryl coupling reactions of indoloterpenes and cycloether formation mediated by a single bacterial flavoenzyme</article-title>. <source>Angewandte Chemie, International Edition</source>, <volume>52</volume>, <fpage>9040</fpage>&#x02013;<lpage>9043</lpage>. <pub-id pub-id-type="pmid">23843280</pub-id></mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Baunach</surname>
<given-names>M.</given-names></string-name>, <string-name><surname>Ding</surname>
<given-names>L.</given-names></string-name>, <string-name><surname>Willing</surname>
<given-names>K.</given-names></string-name>, <string-name><surname>Hertweck</surname>
<given-names>C.</given-names></string-name></person-group> (<year>2015</year>). <article-title>Bacterial synthesis of unusual sulfonamide and sulfone antibiotics by flavoenzyme-mediated sulfur dioxide capture</article-title>. <source>Angewandte Chemie, International Edition</source>, <volume>54</volume>, <fpage>13279</fpage>&#x02013;<lpage>13283</lpage>.<pub-id pub-id-type="pmid">26366473</pub-id></mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blaesse</surname>
<given-names>M.</given-names></string-name>, <string-name><surname>Kupke</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Huber</surname>
<given-names>R.</given-names></string-name>, <string-name><surname>Steinbacher</surname>
<given-names>S.</given-names></string-name></person-group> (<year>2000</year>). <article-title>Crystal structure of the peptidyl-cysteine decarboxylase EpiD complexed with a pentapeptide substrate</article-title>. <source>EMBO Journal</source>, <volume>19</volume>, <fpage>6299</fpage>&#x02013;<lpage>6310</lpage>. <pub-id pub-id-type="pmid">11101502</pub-id></mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Block</surname>
<given-names>E.</given-names></string-name></person-group> (<year>1978</year>). <article-title>Reactions of organosulfur compounds</article-title>, In <person-group person-group-type="editor"><string-name><surname>Blomquist</surname>
<given-names>A. T.</given-names></string-name>, <string-name><surname>Wassermann</surname>
<given-names>H. H.</given-names></string-name></person-group> (Eds.), <source>Organic chemistry: A series of monographs</source> (<edition>1st</edition> ed., Vol. <volume>37</volume>). <publisher-name>Elsevier</publisher-name>.</mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Brooks</surname>
<given-names>G. T.</given-names></string-name></person-group> (<year>1989</year>). In <person-group person-group-type="editor"><string-name><surname>Damani</surname>
<given-names>L. A.</given-names></string-name></person-group> (Ed.), <source>Sulphur-containing drugs and related organic compounds: Metabolism of sulphur-functional groups v. 1A: Chemistry, biochemistry and toxicology (Biochemical Pharmacology S.)</source> (Vol. <volume>1</volume>, <issue>part A</issue>, pp. <fpage>60</fpage>&#x02013;<lpage>93</lpage>). <publisher-name>Ellis Horwood</publisher-name>.</mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>De Meester</surname>
<given-names>I.</given-names></string-name>, <string-name><surname>Korom</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Van Damme</surname>
<given-names>J.</given-names></string-name>, <string-name><surname>Scharp&#x000e9;</surname>
<given-names>S.</given-names></string-name></person-group> (<year>1999</year>). <article-title>CD26, let it cut or cut it down</article-title>. <source>Immunology Today</source>, <volume>20</volume>, <fpage>367</fpage>&#x02013;<lpage>375</lpage>.<pub-id pub-id-type="pmid">10431157</pub-id></mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ding</surname>
<given-names>L.</given-names></string-name>, <string-name><surname>M&#x000fc;nch</surname>
<given-names>J.</given-names></string-name>, <string-name><surname>Goerls</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Maier</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Fiebig</surname>
<given-names>H. H.</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>W. H.</given-names></string-name>, <string-name><surname>Hertweck</surname>
<given-names>C.</given-names></string-name></person-group> (<year>2010</year>). <article-title>Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte</article-title>. <source>Bioorganic &#x00026; Medicinal Chemistry Letters</source>, <volume>20</volume>, <fpage>24</fpage>&#x02013;<lpage>26</lpage>. </mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Feng</surname>
<given-names>X.</given-names></string-name>, <string-name><surname>Al Maharik</surname>
<given-names>N.</given-names></string-name>, <string-name><surname>Bartholom&#x000e9;</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Janso</surname>
<given-names>J. E.</given-names></string-name>, <string-name><surname>Reilly</surname>
<given-names>U.</given-names></string-name>, <string-name><surname>O'Hagan</surname>
<given-names>D.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Incorporation of [<sup>2</sup>H<sub>1</sub>]-(1R,2R)- and [<sup>2</sup>H<sub>1</sub>]-(1S,2R)-glycerols into the antibiotic nucleocidin in <italic toggle="yes">Streptomyces calvus</italic></article-title>. <source>Organic &#x00026; Biomolecular Chemistry</source>, <volume>15</volume>, <fpage>8006</fpage>&#x02013;<lpage>8008</lpage>.<pub-id pub-id-type="pmid">28920128</pub-id></mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Feng</surname>
<given-names>X.</given-names></string-name>, <string-name><surname>Bello</surname>
<given-names>D.</given-names></string-name>, <string-name><surname>Lowe</surname>
<given-names>P. T.</given-names></string-name>, <string-name><surname>Clark</surname>
<given-names>J.</given-names></string-name>, <string-name><surname>O'Hagan</surname>
<given-names>D.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Two 3&#x02032;-<italic toggle="yes">O</italic>-&#x003b2;-glucosylated nucleoside fluorometabolites related to nucleocidin in <italic toggle="yes">Streptomyces calvus</italic></article-title>. <source>Chemical Science</source>, <volume>10</volume>, <fpage>9501</fpage>&#x02013;<lpage>9505</lpage>.<pub-id pub-id-type="pmid">32110306</pub-id></mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ferone</surname>
<given-names>R.</given-names></string-name></person-group> (<year>1977</year>). <article-title>Folate metabolism in malaria</article-title>. <source>Bulletin of the World Health Organization</source>, <volume>55</volume>, <fpage>291</fpage>&#x02013;<lpage>298</lpage>.<pub-id pub-id-type="pmid">338184</pub-id></mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Florini</surname>
<given-names>J. R.</given-names></string-name>, <string-name><surname>Bird</surname>
<given-names>H. H.</given-names></string-name>, <string-name><surname>Bell</surname>
<given-names>P. H.</given-names></string-name></person-group> (<year>1966</year>). <article-title>Inhibition of protein synthesis in vitro and in vivo by nucleocidin, an antitrypanosomal antibiotic</article-title>. <source>Journal of Biological Chemistry</source>, <volume>241</volume>, <fpage>1091</fpage>&#x02013;<lpage>1098</lpage>.<pub-id pub-id-type="pmid">5933868</pub-id></mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Houge-Frydrych</surname>
<given-names>C. S. V.</given-names></string-name>, <string-name><surname>Gilpin</surname>
<given-names>M. L.</given-names></string-name>, <string-name><surname>Skett</surname>
<given-names>P. W.</given-names></string-name>, <string-name><surname>Tyler</surname>
<given-names>J. W.</given-names></string-name></person-group> (<year>2000</year>). <article-title>SB-203207 and SB-203208, two novel isoleucyl from a <italic toggle="yes">Streptomyces</italic> sp. II. Structural determination</article-title>. <source>Journal of Antibiotics</source>, <volume>53</volume>, <fpage>364</fpage>&#x02013;<lpage>372</lpage>. <pub-id pub-id-type="pmid">10866218</pub-id></mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hu</surname>
<given-names>Z.</given-names></string-name>, <string-name><surname>Awakawa</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>Z.</given-names></string-name>, <string-name><surname>Abe</surname>
<given-names>I.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Aminoacyl sulfonamide assembly in SB-203208 biosynthesis</article-title>. <source>Nature Communications</source>, <volume>10</volume>, <comment>Article number 184</comment>
<pub-id pub-id-type="doi">10.1038/s41467-018-08093-x</pub-id></mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname>
<given-names>Y. T.</given-names></string-name>, <string-name><surname>Lyu</surname>
<given-names>S. Y.</given-names></string-name>, <string-name><surname>Chuang</surname>
<given-names>P. H.</given-names></string-name>, <string-name><surname>Hsu</surname>
<given-names>N. S.</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>Y. S.</given-names></string-name>, <string-name><surname>Chan</surname>
<given-names>H. C.</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>C. J.</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Y. C.</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>C. J.</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>W. B.</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>T. L.</given-names></string-name></person-group> (<year>2009</year>). <article-title>In vitro characterization of enzymes involved in the synthesis of nonproteinogenic residue (2S,3S)-beta-methylphenylalanine in glycopeptide antibiotic mannopeptimycin</article-title>. <source>Chembiochem</source>, <volume>10</volume>, <fpage>2480</fpage>&#x02013;<lpage>2487</lpage>. <pub-id pub-id-type="pmid">19731276</pub-id></mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Humm</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Fritsche</surname>
<given-names>E.</given-names></string-name>, <string-name><surname>Steinbacher</surname>
<given-names>S.</given-names></string-name></person-group> (<year>1997</year>). <article-title>Structure and reaction mechanism of <sc>l</sc>-arginine:glycine amidinotransferase</article-title>. <source>Biological Chemistry</source>, <volume>378</volume>, <fpage>193</fpage>&#x02013;<lpage>197</lpage>.<pub-id pub-id-type="pmid">9165070</pub-id></mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Isono</surname>
<given-names>K.</given-names></string-name>, <string-name><surname>Uramoto</surname>
<given-names>M.</given-names></string-name>, <string-name><surname>Kusakabe</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Miyata</surname>
<given-names>N.</given-names></string-name>, <string-name><surname>Koyama</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Ubukata</surname>
<given-names>M.</given-names></string-name>, <string-name><surname>Sethi</surname>
<given-names>S. K.</given-names></string-name>, <string-name><surname>McCloskey</surname>
<given-names>J. A.</given-names></string-name></person-group> (<year>1984</year>). <article-title>Dealanylascamycin, nucleoside antibiotics from <italic toggle="yes">Streptomyces</italic> sp</article-title>. <source>Journal of Antibiotics (Tokyo)</source>, <volume>37</volume>, <fpage>670</fpage>&#x02013;<lpage>672</lpage>. </mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Q.</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>G.</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Tian</surname>
<given-names>X.</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Ju</surname>
<given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>C.</given-names></string-name></person-group> (<year>2012</year>). <article-title>Identification and characterization of xiamycin A and oxiamycin gene cluster reveals an oxidative cyclization strategy tailoring indolosesquiterpene biosynthesis</article-title>. <source>Journal of American Chemical Society</source>, <volume>134</volume>, <fpage>8996</fpage>&#x02013;<lpage>9005</lpage>. </mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
<given-names>J.</given-names></string-name>, <string-name><surname>Koto</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Davis</surname>
<given-names>I.</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>A.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Probing the Cys-Tyr cofactor biogenesis in cysteine dioxygenase by the genetic incorporation of fluorotyrosine</article-title>. <source>Biochemistry</source>, <volume>58</volume>, <fpage>2218</fpage>&#x02013;<lpage>2227</lpage>. <pub-id pub-id-type="pmid">30946568</pub-id></mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matsuda</surname>
<given-names>M.</given-names></string-name>, <string-name><surname>Iino</surname>
<given-names>M.</given-names></string-name>, <string-name><surname>Hirayama</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Miyashira</surname>
<given-names>T.</given-names></string-name></person-group> (<year>1972</year>). <article-title>Radical Copolymerization of sulfur dioxide and styrene</article-title>. <source>Macromolecules</source>, <volume>5</volume>, <fpage>240</fpage>&#x02013;<lpage>246</lpage>. </mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McCaw</surname>
<given-names>P. G.</given-names></string-name>, <string-name><surname>Buckley</surname>
<given-names>N. M.</given-names></string-name>, <string-name><surname>Collins</surname>
<given-names>S. G.</given-names></string-name>, <string-name><surname>Maguire</surname>
<given-names>A. R.</given-names></string-name></person-group> (<year>2016</year>). <article-title>Generation, reactivity and uses of sulfines in organic synthesis</article-title>. <source>European Journal of Organic Chemistry</source>, <volume>9</volume>, <fpage>1630</fpage>&#x02013;<lpage>1650</lpage>. </mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Morton</surname>
<given-names>G. O.</given-names></string-name>, <string-name><surname>Lancaster</surname>
<given-names>J. E.</given-names></string-name>, <string-name><surname>Van Lear</surname>
<given-names>G. E.</given-names></string-name>, <string-name><surname>Fulmor</surname>
<given-names>W.</given-names></string-name>, <string-name><surname>Meyer</surname>
<given-names>W. E.</given-names></string-name></person-group> (<year>1969</year>). <article-title>The structure of nucleocidin. III (revised structure)</article-title>. <source>Journal of American Chemical Society</source>, <volume>91</volume>, <fpage>1535</fpage>&#x02013;<lpage>1537</lpage>. </mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Negishi</surname>
<given-names>M.</given-names></string-name>, <string-name><surname>Pedersen</surname>
<given-names>L. G.</given-names></string-name>, <string-name><surname>Petrotchenko</surname>
<given-names>E.</given-names></string-name>, <string-name><surname>Shevtsov</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Gorokhov</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Kakuta</surname>
<given-names>Y.</given-names></string-name>, <string-name><surname>Pedersen</surname>
<given-names>L. C.</given-names></string-name></person-group> (<year>2001</year>). <article-title>Structure and function of sulfotransferases</article-title>. <source>Archives of Biochemistry and Biophysics</source>, <volume>390</volume>, <fpage>149</fpage>&#x02013;<lpage>157</lpage>. <pub-id pub-id-type="pmid">11396917</pub-id></mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ogasawara</surname>
<given-names>Y.</given-names></string-name>, <string-name><surname>Dairi</surname>
<given-names>T.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Biosynthesis of oligopeptides using ATP-Grasp enzymes</article-title>. <source>Chemistry</source>, <volume>23</volume>, <fpage>10714</fpage>&#x02013;<lpage>10724</lpage>. <pub-id pub-id-type="pmid">28488371</pub-id></mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>O'Hagan</surname>
<given-names>D.</given-names></string-name>, <string-name><surname>Schaffrath</surname>
<given-names>C.</given-names></string-name>, <string-name><surname>Cobb</surname>
<given-names>S. L.</given-names></string-name>, <string-name><surname>Hamilton</surname>
<given-names>J. T.</given-names></string-name>, <string-name><surname>Murphy</surname>
<given-names>C. D.</given-names></string-name></person-group> (<year>2002</year>). <article-title>Biosynthesis of an organofluorine molecule</article-title>. <source>Nature</source>, <volume>416</volume>, <fpage>279</fpage>&#x02013;<lpage>279</lpage>. </mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Osada</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Isono</surname>
<given-names>K.</given-names></string-name></person-group> (<year>1985</year>). <article-title>Mechanism of action and selective toxicity of ascamycin, a nucleoside antibiotic</article-title>. <source>Antimicrobial Agents and Chemotherapy</source>, <volume>27</volume>, <fpage>230</fpage>&#x02013;<lpage>233</lpage>. <pub-id pub-id-type="pmid">2580481</pub-id></mixed-citation></ref><ref id="bib28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Osada</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Isono</surname>
<given-names>K.</given-names></string-name></person-group> (<year>1986</year>). <article-title>Purification and characterization of ascamycin-hydrolysing aminopeptidase from <italic toggle="yes">Xanthomonas citri</italic></article-title>. <source>Biochemical Journal</source>, <volume>233</volume>, <fpage>459</fpage>&#x02013;<lpage>463</lpage>. <pub-id pub-id-type="pmid">3754135</pub-id></mixed-citation></ref><ref id="bib29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Petkowski</surname>
<given-names>J. J.</given-names></string-name>, <string-name><surname>Bains</surname>
<given-names>W.</given-names></string-name>, <string-name><surname>Seager</surname>
<given-names>S.</given-names></string-name></person-group> (<year>2018</year>). <article-title>Natural products containing a nitrogen-sulfur bond</article-title>. <source>Journal of Natural Products</source>, <volume>81</volume>, <fpage>423</fpage>&#x02013;<lpage>446</lpage>. <pub-id pub-id-type="pmid">29364663</pub-id></mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stefanska</surname>
<given-names>A. L.</given-names></string-name>, <string-name><surname>Cassels</surname>
<given-names>R.</given-names></string-name>, <string-name><surname>Ready</surname>
<given-names>S. J.</given-names></string-name>, <string-name><surname>Warr</surname>
<given-names>S. R.</given-names></string-name></person-group> (<year>2000</year>). <article-title>SB-203207 and SB-203208, two novel isoleucyl from a <italic toggle="yes">Streptomyces</italic> sp. I. Fermentation, isolation and properties</article-title>. <source>Journal of Antibiotics</source>, <volume>53</volume>, <fpage>357</fpage>&#x02013;<lpage>363</lpage>. <pub-id pub-id-type="pmid">10866217</pub-id></mixed-citation></ref><ref id="bib31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stipanuk</surname>
<given-names>M. H.</given-names></string-name>, <string-name><surname>Simmons</surname>
<given-names>C. R.</given-names></string-name>, <string-name><surname>Karplus</surname>
<given-names>P. A.</given-names></string-name>, <string-name><surname>Dominy</surname>
<given-names>J. E.</given-names><suffix>Jr</suffix></string-name></person-group> (<year>2011</year>). <article-title>Thiol dioxygenases: Unique families of cupin proteins</article-title>. <source>Amino Acids</source>, <volume>41</volume>, <fpage>91</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="pmid">20195658</pub-id></mixed-citation></ref><ref id="bib32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Takahashi</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Ikeda</surname>
<given-names>D.</given-names></string-name>, <string-name><surname>Nakamura</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Naganawa</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Kurasawa</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Okami</surname>
<given-names>Y.</given-names></string-name>, <string-name><surname>Takeuchi</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Iitaka</surname>
<given-names>Y.</given-names></string-name></person-group> (<year>1989</year>). <article-title>Altemicidin, a new acaricidal and antitumor substance. II. Structure determination</article-title>. <source>Journal of Antibiotics</source>, <volume>42</volume>, <fpage>1562</fpage>&#x02013;<lpage>1566</lpage>. <pub-id pub-id-type="pmid">2584138</pub-id></mixed-citation></ref><ref id="bib33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Takahashi</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Kurasawa</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Ikeda</surname>
<given-names>D.</given-names></string-name>, <string-name><surname>Okami</surname>
<given-names>Y.</given-names></string-name>, <string-name><surname>Takeuchi</surname>
<given-names>T.</given-names></string-name></person-group> (<year>1989</year>). <article-title>Altemicidin, a new acaricidal and antitumor substance. I. Taxonomy, fermentation, isolation and physico-chemical and biological properties</article-title>. <source>Journal of Antibiotics</source>, <volume>42</volume>, <fpage>1556</fpage>&#x02013;<lpage>1561</lpage>. <pub-id pub-id-type="pmid">2584137</pub-id></mixed-citation></ref><ref id="bib34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Takahashi</surname>
<given-names>E.</given-names></string-name>, <string-name><surname>Beppu</surname>
<given-names>T.</given-names></string-name></person-group> (<year>1982</year>). <article-title>A new nucleosidic antibiotic AT-265</article-title>. <source>Journal of Antibiotics (Tokyo)</source>
<volume>35</volume>, <fpage>939</fpage>&#x02013;<lpage>947</lpage>. </mixed-citation></ref><ref id="bib35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tang</surname>
<given-names>X.</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>J.</given-names></string-name>, <string-name><surname>Mill&#x000e1;n-Agui&#x000f1;aga</surname>
<given-names>N.</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>J. J.</given-names></string-name>, <string-name><surname>O'Neill</surname>
<given-names>E. C.</given-names></string-name>, <string-name><surname>Ugalde</surname>
<given-names>J. A.</given-names></string-name>, <string-name><surname>Jensen</surname>
<given-names>P. R.</given-names></string-name>, <string-name><surname>Mantovani</surname>
<given-names>S. M.</given-names></string-name>, <string-name><surname>Moore</surname>
<given-names>B. S.</given-names></string-name></person-group> (<year>2015</year>). <article-title>Identification of thiotetronic acid antibiotic biosynthetic pathways by target-directed genome mining</article-title>. <source>ACS Chemical Biology</source>, <volume>10</volume>, <fpage>2841</fpage>&#x02013;<lpage>2849</lpage>. <pub-id pub-id-type="pmid">26458099</pub-id></mixed-citation></ref><ref id="bib36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Waldman</surname>
<given-names>A. J.</given-names></string-name>, <string-name><surname>Ng</surname>
<given-names>T. L.</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>P.</given-names></string-name>, <string-name><surname>Balskus</surname>
<given-names>E. P.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Heteroatom&#x02013;heteroatom bond formation in natural product biosynthesis</article-title>. <source>Chemical Reviews</source>, <volume>117</volume>, <fpage>5784</fpage>&#x02013;<lpage>5863</lpage>. <pub-id pub-id-type="pmid">28375000</pub-id></mixed-citation></ref><ref id="bib37"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Walsh</surname>
<given-names>C. T.</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>Y.</given-names></string-name></person-group> (<year>2017</year>). <source>Natural product biosynthesis: Chemical logic and enzymatic machinery</source>. <publisher-name>Royal Society of Chemistry</publisher-name>.</mixed-citation></ref><ref id="bib38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xu</surname>
<given-names>Z.</given-names></string-name>, <string-name><surname>Baunach</surname>
<given-names>M.</given-names></string-name>, <string-name><surname>Ding</surname>
<given-names>L.</given-names></string-name>, <string-name><surname>Hertweck</surname>
<given-names>C.</given-names></string-name></person-group> (<year>2012</year>). <article-title>Bacterial synthesis of diverse indole terpene alkaloids by an unparalleled cyclization sequence</article-title>. <source>Angewandte Chemie, International Edition</source>, <volume>124</volume>, <fpage>10439</fpage>&#x02013;<lpage>10443</lpage>. </mixed-citation></ref><ref id="bib39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yan</surname>
<given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>N.</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>Y.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Recent developments in self-resistance gene directed natural product discovery</article-title>. <source>Natural Product Reports</source>, <volume>37</volume>, <fpage>879</fpage>&#x02013;<lpage>892</lpage>. <pub-id pub-id-type="pmid">31912842</pub-id></mixed-citation></ref><ref id="bib40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yan</surname>
<given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Q.</given-names></string-name>, <string-name><surname>Zang</surname>
<given-names>X.</given-names></string-name>, <string-name><surname>Yuan</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Bat-Erdene</surname>
<given-names>U.</given-names></string-name>, <string-name><surname>Nguyen</surname>
<given-names>C.</given-names></string-name>, <string-name><surname>Gan</surname>
<given-names>J.</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>J.</given-names></string-name>, <string-name><surname>Jacobsen</surname>
<given-names>S. E.</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>Y.</given-names></string-name></person-group> (<year>2018</year>). <article-title>Resistance-gene-directed discovery of a natural-product herbicide with a new mode of action</article-title>. <source>Nature</source>, <volume>559</volume>, <fpage>415</fpage>&#x02013;<lpage>418</lpage>. <pub-id pub-id-type="pmid">29995859</pub-id></mixed-citation></ref><ref id="bib41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>Q.</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>L.</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>Y.</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>Y.</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>L.</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>S. M.</given-names></string-name>, <string-name><surname>Shen</surname>
<given-names>Y.</given-names></string-name>, <string-name><surname>Tian</surname>
<given-names>C.</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>H. W.</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>C.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Characterization of the flavoenzyme XiaK as an <italic toggle="yes">N</italic>-hydroxylase and implications in indolosesquiterpene diversification</article-title>. <source>Chemical Science</source>, <volume>8</volume>, <fpage>5067</fpage>&#x02013;<lpage>5077</lpage>. <pub-id pub-id-type="pmid">28970893</pub-id></mixed-citation></ref><ref id="bib42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>Q.</given-names></string-name>, <string-name><surname>M&#x000e1;ndi</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>W.</given-names></string-name>, <string-name><surname>Tian</surname>
<given-names>X.</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>H.</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>W.</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Ju</surname>
<given-names>J.</given-names></string-name>, <string-name><surname>Kurt&#x000e1;n</surname>
<given-names>T.</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>C.</given-names></string-name></person-group> (<year>2012</year>). <article-title>N&#x02013;N-coupled indolo-sesquiterpene atropo-diastereomers from a marine-derived actinomycete</article-title>. <source>European Journal of Organic Chemistry</source>, <volume>27</volume>, <fpage>5256</fpage>&#x02013;<lpage>5262</lpage>. </mixed-citation></ref><ref id="bib43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname>
<given-names>C.</given-names></string-name>, <string-name><surname>Qi</surname>
<given-names>J.</given-names></string-name>, <string-name><surname>Tao</surname>
<given-names>W.</given-names></string-name>, <string-name><surname>He</surname>
<given-names>L.</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>W.</given-names></string-name>, <string-name><surname>Chan</surname>
<given-names>J.</given-names></string-name>, <string-name><surname>Deng</surname>
<given-names>Z.</given-names></string-name></person-group> (<year>2014</year>). <article-title>Characterization of biosynthetic genes of ascamycin/dealanylascamycin featuring a 5&#x02032;-<italic toggle="yes">O</italic>-sulfonamide moiety in <italic toggle="yes">Streptomyces</italic> sp. JCM9888</article-title>. <source>PLoS One</source>, <volume>9</volume>, <fpage>1</fpage>&#x02013;<lpage>15</lpage>. </mixed-citation></ref><ref id="bib44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhu</surname>
<given-names>X. M.</given-names></string-name>, <string-name><surname>Hackl</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Thaker</surname>
<given-names>M. N.</given-names></string-name>, <string-name><surname>Kalan</surname>
<given-names>L.</given-names></string-name>, <string-name><surname>Weber</surname>
<given-names>C.</given-names></string-name>, <string-name><surname>Urgast</surname>
<given-names>D. S.</given-names></string-name>, <string-name><surname>Krupp</surname>
<given-names>E. M.</given-names></string-name>, <string-name><surname>Brewer</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Vanner</surname>
<given-names>S.</given-names></string-name>, <string-name><surname>Szawiola</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Yim</surname>
<given-names>G.</given-names></string-name>, <string-name><surname>Feldmann</surname>
<given-names>J.</given-names></string-name>, <string-name><surname>Bechthold</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Wright</surname>
<given-names>G. D.</given-names></string-name>, <string-name><surname>Zechel</surname>
<given-names>D. L.</given-names></string-name></person-group> (<year>2015</year>). <article-title>Biosynthesis of the fluorinated natural product nucleocidin in <italic toggle="yes">Streptomyces calvus</italic> is dependent on the bldA-specified Leu-tRNA(UUA) molecule</article-title>. <source>ChemBioChem</source>, <volume>16</volume>, <fpage>2498</fpage>&#x02013;<lpage>2506</lpage>. <pub-id pub-id-type="pmid">26374477</pub-id></mixed-citation></ref></ref-list></back></article>